A Duke University spinoff has reached a milestone in tissue engineering as it transplanted the first bioengineered blood vessel into the arm of a patient with end-stage kidney disease. In its first U.S. clinical trial, Humacyte is testing the safety and effectiveness of the blood vessel, which is intended to be an off-the-shelf product that’s […]
A new mobile health startup is bringing together industry and academia to help providers and payers address patient non-compliance. Improved Patient Outcomes Inc. (IPO) is a new joint venture spun around research from Duke University and mobile health technology from Cleveland company CellepathicRx. CellepathicRx designs mobile messaging programs that use reminders, educational messages, motivational messages […]
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
If personalized medicine’s promise isn’t easily understood, Dr. Kristin Newby can readily explain it through her clinical practice. The cardiologist at the Duke University Medical Center in Durham, North Carolina routinely sees patients who have had a heart attack or are at risk for one. But some of them had heart attacks without showing any […]
Companies like Starbucks (NASDAQ:SBUX), Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) aren’t healthcare companies, but one venture capitalist believes their example can guide personalized medicine. Bob Kocher, a partner at venture capital firm Venrock, said that these consumer-focused companies have all taken steps toward personalizing their offerings. Personalization increases the value of those offerings and helps the […]
For those counting, today is day 3,273 since the sequencing of the human genome was completed. Eric Green, director of the National Human Genome Research Institute, is among those counting. Medicine based on genomic information promises new advances for healthcare as technology gives clinicians new tools to make diagnostic and treatment decisions based on a […]
Some of most electrifying March Madness moments actually happen on the sidelines. During timeouts or other breaks in the action, look for trainers affixing electrodes to the area around an athlete’s injured muscle or joint. The wires plug into a small device that sends electrical signals to temporarily relieve pain. “Most of the players just […]
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Duke University visits Chapel Hill tonight to play the University of North Carolina in a men’s college basketball matchup that will keep at least two-thirds of Research Triangle basketball fans riveted tonight. Even basketball observers outside of the Triangle call it the biggest rivalry in sports, or at least in college basketball. But the longtime […]
The prostate cancer test to confirm a diagnosis is an uncomfortable medical procedure with an equally awkward name — the transrectal biopsy. This intrusive test uses an ultrasound probe and needle to retrieve a tissue sample for analysis. Even when the biopsy causes no pain, it sparks plenty of patient anxiety. Duke University researchers have […]
AIDS research efforts at Duke University have landed three grants totaling $37.2 million from the Bill & Melinda Gates Foundation. The grants will fund Duke University Medical Center HIV work in the Collaboration for AIDS Vaccine Discovery (CAVD) program, an international network of scientists working to bring new HIV vaccine candidates into clinical trials. The […]
Duke University is partnering with the North Carolina Research Campus in an expansion of an Alzheimer's disease study that aims to find new ways to predict and treat the disease. Research initially began in 2007 to study disease patterns over the long term for patients in the city of Kannapolis, North Carolina, where the N.C. Research Campus is based, as well as surrounding Cabarrus County. Researchers are expanding the "Measurement to Understand the Reclassification of Disease of Cabarrus/Kannapolis" or MURDOCK study to include participants 55 and older who have not been diagnosed with Alzheimer's disease and live in outlying areas surrounding Cabarrus County.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Duke University Medical Center is working with Durham County, North Carolina to map diabetes in the community in a new health IT effort to track and manage the disease. Duke and the Durham County Department of Health and Human Services will receive $6.25 million over five years to develop and implement programs to help people […]
Duke University Medical Center has been awarded a $25 million federal grant to research epilepsy in an effort to understand its genetic roots and develop new treatments for the disorder. The National Institute of Neurological Diseases and Stroke, a part of the National Institutes of Health, funded the grant as part of its “Center Without […]
Duke University is partnering with Verizon (NYSE:VZ) in a health IT initiative pursuing technologies intended to improve care, expand healthcare access and lower costs. The agreement pairs Duke’s research resources with Verizon Connected Healthcare Solutions, the telecom giant’s healthcare practice group. Duke will make available personnel, including research and project management experts. Intellectual property from […]
A smokeless nicotine-delivery system developed by a Duke University researcher is now in the hands of tobacco industry giant Philip Morris International (NYSE:PM). Philip Morris has purchased the patent and global rights to an aerosol nicotine-delivery system developed by Jed Rose, who is director of Duke’s Center for Nicotine and Smoking Cessation Research. Financial terms […]
Duke University researchers have found that cells that play a role in triggering a response to bacteria and pathogens could also have a role in attacking dengue fever, a tropical disease for which there is no vaccine. A Duke research team at the Duke-NUS Graduate Medical School in Singapore studied mast cells in mice. Mast […]